USA |PINK |USD |ADR
|Public Float||P/E Ratio||32.28|
|% Short of Float||-||Dividend (Yield)||50.00 (0.03%)|
|Held by Insiders||-||Ex-Dividend Date||Mar 29, 2022|
|Held by Institutions||0.07%||IPO Date||-|
|Mar 22||Mar 21||Mar 20|
|Mar 22||Dec 21||Sep 21|
Astellas pharma inc trades on the OTC Markets stock market in USA under the ticker symbol "ALPMY". Astellas pharma inc’s stock symbol can also be displayed as "OTCMKTS:ALPMY".
Astellas pharma inc (OTCMKTS:ALPMY) is owned by 0.07% institutional shareholders and by 0.00% insiders. The rest is owned by the public.
Explore More Details on Astellas pharma inc's “Ownership” Section
Astellas pharma inc's key executive team includes the following managers:
Astellas pharma inc (OTCMKTS:ALPMY) is classified under the "Healthcare" sector and under the "Drug Manufacturers-General" industry.
Currently the number of employees working for Astellas pharma inc is 0.
Astellas pharma inc (OTCMKTS:ALPMY) is headquartered in Japan.
Astellas pharma inc’s mailing address is 2-5-1, Nihonbashi-Honcho, Tokyo, Japan, 103-8411.
The company’s phone number is 81 3 3244 3000.